The Ledger / Alain Merieux & family
Alain Merieux & family
◼ Origin
Inherited Institut Mérieux from his father Marcel Mérieux; transformed it into bioMérieux, a global diagnostics company (founded in standalone form 1963), listed on Euronext Paris in 2004.
◼ Self-Made Verdict — PARTIAL
Inherited Institut Mérieux from his father Marcel; built bioMérieux into a global diagnostics company, blending inheritance with substantial operational development.
◼ Documented marks
01
Chairs Institut Mérieux and holds a controlling stake in bioMérieux SA (Euronext: BIM), the world's third-largest diagnostics company with €3.6B revenue — products range from blood-culture systems to molecular diagnostics.
02
bioMérieux disclosed a cyberattack in March 2020 that disrupted operations during the early COVID-19 pandemic, raising questions about critical healthcare infrastructure security.
03
The Mérieux family funds biological research institutes (IMBA, Fondation Mérieux) while maintaining commercial control of the diagnostics group — a structure criticized by some researchers for blurring philanthropic and commercial interests.
No inheritance, or primary accounts documented for this billionaire yet.
◼ List of charges
No documented charges yet.
These are moral charges, not legal ones. The actual legal system has not — and will not — bring them.
More ledger entries